Vaccinology

  • Funded by UK Research and Innovation (UKRI)
  • Total publications:88 publications

Grant number: MC_UU_00033/2

Grant search

Key facts

  • Disease

    Rift Valley fever
  • Start & end year

    2023
    2028
  • Known Financial Commitments (USD)

    $0
  • Funder

    UK Research and Innovation (UKRI)
  • Principal Investigator

    N/A

  • Research Location

    N/A
  • Lead Research Institution

    N/A
  • Research Priority Alignment

    N/A
  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    Clinical trial (unspecified trial phase)

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    Unspecified

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Vaccines are among the most successful tools available for protecting public health, but effective vaccines are still lacking for many infectious diseases that are important in Africa â€Â" including HIV, viruses that cause major outbreaks in African populations, and parasitic diseases including worm infections. As well, vaccines work better in some communities than others, with poor communities in rural, low-income, tropical settings often at a disadvantage. Our theme will contribute to • Developing new vaccines of particular importance for Africa, and testing them in clinical trials â€Â" for example vaccines against viruses such as Rift Valley Fever which causes outbreaks among humans and farm animals in East Africa, and against debilitating worm infections such as schistosomiasis • Understanding how best to employ vaccines in Africa â€Â" for example how vaccines can be combined with other preventive measures against HIV, or what the most appropriate dosing schedules are for particular age groups and needs • Investigating why some vaccines work differently in different communities, and working with communities to develop strategies that enable them to benefit from vaccines to the full • Understanding how different communities learn about, understand and perceive vaccines, and what makes people confident to use them • Building vaccine research expertise among African researchers This work will contribute to ensuring that African communities secure the maximum possible benefit from vaccines.

Publicationslinked via Europe PMC

Last Updated:an hour ago

View all publications at Europe PMC

A Longitudinal Analysis of Memory Immune Responses in Convalescent Crimean-Congo Hemorrhagic Fever Survivors in Uganda.

Effectiveness of the primary Bacillus Calmette-Guérin vaccine against the risk of Mycobacterium tuberculosis infection and tuberculosis disease: a meta-analysis of individual participant data.

Contraceptive use, prevalence and incidence of pregnancy and associated factors among women participating in a vaccine preparedness cohort study in Masaka, Uganda, a retrospective secondary analysis.

Schistosome and malaria exposure and urban-rural differences in vaccine responses in Uganda: a causal mediation analysis using data from three linked randomised controlled trials.

The effect of intermittent preventive treatment for malaria with dihydroartemisinin-piperaquine on vaccine-specific responses among schoolchildren in rural Uganda (POPVAC B): a double-blind, randomised controlled trial.

Associations of poor water, sanitation, and hygiene and parasite burden with markers of environmental enteric dysfunction in preschool-age children infected with Schistosoma mansoni in Uganda.

The effect of intensive praziquantel administration on vaccine-specific responses among schoolchildren in Ugandan schistosomiasis-endemic islands (POPVAC A): an open-label, randomised controlled trial.

Intersecting social and environmental determinants of multidrug-resistant urinary tract infections in East Africa beyond antibiotic use.

Impaired Mycobacterium tuberculosis-specific T-cell memory phenotypes and functional profiles among adults with type 2 diabetes mellitus in Uganda.